Showing 1 to 3 of 3 results


US Cuts $500 Million in mRNA Vaccine Research Funding
The US Department of Health and Human Services, led by Robert F. Kennedy Jr., slashed $500 million in mRNA vaccine research funding, citing ineffective protection against respiratory infections, despite expert consensus on the technology's life-saving role during the COVID-19 pandemic and its potent...
US Cuts $500 Million in mRNA Vaccine Research Funding
The US Department of Health and Human Services, led by Robert F. Kennedy Jr., slashed $500 million in mRNA vaccine research funding, citing ineffective protection against respiratory infections, despite expert consensus on the technology's life-saving role during the COVID-19 pandemic and its potent...
Progress
48% Bias Score


Ousted Vaccine Experts Criticize Replacement Panel's Lack of Scientific Rigor
Seventeen experts fired from a U.S. vaccine advisory committee published a commentary in the New England Journal of Medicine criticizing their replacements for prioritizing an anti-vaccine advocate's presentation over CDC data and recommending the removal of a vaccine preservative despite lacking ev...
Ousted Vaccine Experts Criticize Replacement Panel's Lack of Scientific Rigor
Seventeen experts fired from a U.S. vaccine advisory committee published a commentary in the New England Journal of Medicine criticizing their replacements for prioritizing an anti-vaccine advocate's presentation over CDC data and recommending the removal of a vaccine preservative despite lacking ev...
Progress
48% Bias Score

US Halts $500 Million in mRNA Vaccine Funding
The US government, under Health Secretary Robert F. Kennedy Jr., stopped funding for 22 mRNA vaccine projects worth nearly $500 million due to concerns about their effectiveness against respiratory illnesses; this reflects a broader policy shift towards vaccine skepticism.

US Halts $500 Million in mRNA Vaccine Funding
The US government, under Health Secretary Robert F. Kennedy Jr., stopped funding for 22 mRNA vaccine projects worth nearly $500 million due to concerns about their effectiveness against respiratory illnesses; this reflects a broader policy shift towards vaccine skepticism.
Progress
60% Bias Score
Showing 1 to 3 of 3 results